PMC:7546716 / 37591-37949 7 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T171 | 0-358 | Sentence | denotes | Anti-GM-CSF (eg, mavrilimumab, gimsilumab, lenzilumab, otilimab) GM-CSF Type 2 pneumocytes, monocytes, macrophages, neutrophils, endothelial cells Encouraging preliminary data in severe-to-critical COVID-19 and good safety Might be less effective at earlier stages; possibly interferes with alveolar macrophage homoeostasis and alveolar surfactant production |